Susquehanna Fundamental Investments’s BioNTech BNTX Stock Holding History

Susquehanna Fundamental Investments’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,445	Closed	-$994K	–	510
2025 Q4	$994K	Sell	10,445 -30,942	-75%	-$3.12M	0.03%	348
2025 Q3	$4.08M	Sell	41,387 -90,135	-69%	-$9.64M	0.16%	161
2025 Q2	$14M	Sell	131,522 -14,165	-10%	-$1.43M	0.38%	78
2025 Q1	$13.3M	Buy	145,687 +22,030	+18%	+$2.47M	0.19%	132
2024 Q4	$14.1M	Buy	+123,657	New	+$14.1M	0.2%	127
2021 Q2	–	Sell	-17,900	Closed	-$1.96M	–	1655
2021 Q1	$1.96M	Hold	17,900	–	–	0.03%	661
2020 Q4	$1.46M	Hold	17,900	–	–	0.03%	728
2020 Q3	$1.24M	Hold	17,900	–	–	0.04%	568
2020 Q2	$1.2M	Buy	+17,900	New	+$894K	0.06%	410

Other funds holding BNTX

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Susquehanna Fundamental Investments's BNTX Position: Q1 2026 in Review

Susquehanna Fundamental Investments sold out of BioNTech (BNTX) in Q1 2026, closing a stake of 10,445 shares — an estimated $994K sold.

Susquehanna Fundamental Investments first reported a position in BNTX in Q2 2020 and held it in 9 quarters. The position peaked at $14.1M in Q4 2024. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

Susquehanna Fundamental Investments reported no remaining BioNTech position as of Q1 2026 after selling out during the quarter.
Susquehanna Fundamental Investments sold 10,445 BioNTech shares in Q1 2026, an estimated $994K.
Susquehanna Fundamental Investments first reported a position in BioNTech in Q2 2020 and held it in 9 quarters.
Susquehanna Fundamental Investments's BioNTech position peaked at $14.1M in Q4 2024.
272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2026, filed 15 May 2026.